Jonah Sacha, Ph.D., secures $1 million in funding for HIV vaccine research

Back in January we announced that Louis Picker, M.D., and his research team had received $8 million from the Bill & Melinda Gates Foundation to further develop a promising HIV vaccine candidate. OHSU researchers have secured an additional $1 million from the Gates Foundation through their Grand Challenges Explorations funding program.

Research will be led by assistant scientist Jonah Sacha, Ph.D., at the Vaccine and Gene Therapy Institute on OHSU’s West Campus. Sacha and his colleagues will attempt to develop a protective, anti-body based AIDS vaccine that prevents the virus from infecting the host, a goal that has eluded scientists for years. Instead of targeting the highly mutable virus itself, the new approach will target a surrogate marker of HIV infection to block the transmission of HIV.

Read the OHSU News release.

Bookmark and Share

Comments

  1. congrats, Jonah! I sent this post to ana

About the Author

Welcome to the Research News Blog

Welcome to the Research News Blog

OHSU Research News is your portal to information about all things research at Oregon Health & Science University. Visit often for updates on events, discoveries, and important funding information.

Read more

Participation Guidelines

Remember: information you share here is public; it isn't medical advice. Need advice or treatment? Contact your healthcare provider directly. Read our Terms of Use and this disclaimer for details.

Categories

Archives